Pharmacological options in the treatment of benign prostatic hyperplasia.

Article Details

Citation

Copy to clipboard

Kenny B, Ballard S, Blagg J, Fox D

Pharmacological options in the treatment of benign prostatic hyperplasia.

J Med Chem. 1997 Apr 25;40(9):1293-315.

PubMed ID

9135028 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Binding Properties

Drug	Target	Property	Measurement	pH	Temperature (°C)
Finasteride	3-oxo-5-alpha-steroid 4-dehydrogenase 1	Ki (nM)	150	N/A	N/A	Details
Finasteride	3-oxo-5-alpha-steroid 4-dehydrogenase 2	IC 50 (nM)	0.18	N/A	N/A	Details